Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Piraino

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Toxicology|December 19, 2025
Retrospective analysis of clinical laboratory parameters in Han Wistar rat controlsRupert Kellner, Alexander Amberg, Frank Bringezu, et al.
Digital Biomarkers|January 14, 2021
A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D ApproachLynn Rochester, Claudia Mazzà, Arne Mueller, et al.
Leukemia|February 16, 2020
Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphomaGeorg Lenz, Eliza Hawkes, Gregor Verhoef, et al.
Cell Reports|April 8, 2016
mTORC1 Inhibition Corrects Neurodevelopmental and Synaptic Alterations in a Human Stem Cell Model of Tuberous SclerosisVeronica Costa, Stefan Aigner, Mirko Vukcevic, et al.
Digital Biomarkers|October 21, 2020
Real-Life Multimarker Monitoring in Patients with Heart Failure: Continuous Remote Monitoring of Mobility and Patient-Reported Outcomes as Digital End Points in Future Heart-Failure TrialsFrank Kramer, Javed Butler, Sanjiv J Shah, et al.
BMJ Open|July 22, 2020
Walking-related digital mobility outcomes as clinical trial endpoint measures: protocol for a scoping reviewAshley Marie Polhemus, Ronny Bergquist, Magda Bosch de Basea, et al.
Plos One|October 6, 2022
Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement-the Mobilise-D study protocolA Stefanie Mikolaizak, Lynn Rochester, Walter Maetzler, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Toxicology|December 19, 2025
Retrospective analysis of clinical laboratory parameters in Han Wistar rat controlsRupert Kellner, Alexander Amberg, Frank Bringezu, et al.
Digital Biomarkers|January 14, 2021
A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D ApproachLynn Rochester, Claudia Mazzà, Arne Mueller, et al.
Leukemia|February 16, 2020
Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphomaGeorg Lenz, Eliza Hawkes, Gregor Verhoef, et al.
Cell Reports|April 8, 2016
mTORC1 Inhibition Corrects Neurodevelopmental and Synaptic Alterations in a Human Stem Cell Model of Tuberous SclerosisVeronica Costa, Stefan Aigner, Mirko Vukcevic, et al.
Digital Biomarkers|October 21, 2020
Real-Life Multimarker Monitoring in Patients with Heart Failure: Continuous Remote Monitoring of Mobility and Patient-Reported Outcomes as Digital End Points in Future Heart-Failure TrialsFrank Kramer, Javed Butler, Sanjiv J Shah, et al.
BMJ Open|July 22, 2020
Walking-related digital mobility outcomes as clinical trial endpoint measures: protocol for a scoping reviewAshley Marie Polhemus, Ronny Bergquist, Magda Bosch de Basea, et al.
Plos One|October 6, 2022
Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement-the Mobilise-D study protocolA Stefanie Mikolaizak, Lynn Rochester, Walter Maetzler, et al.
Pageof 2